These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15714117)

  • 21. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
    Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
    Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
    Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
    Mill CP; Gettinger KL; Riese DJ
    Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling.
    Wandinger SK; Lahortiga I; Jacobs K; Klammer M; Jordan N; Elschenbroich S; Parade M; Jacoby E; Linders JT; Brehmer D; Cools J; Daub H
    PLoS One; 2016; 11(1):e0146100. PubMed ID: 26745281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
    Wilson KJ; Mill CP; Gallo RM; Cameron EM; VanBrocklin H; Settleman J; Riese DJ
    Biochem J; 2012 Apr; 443(1):133-44. PubMed ID: 22216880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line.
    Fallon KB; Havlioglu N; Hamilton LH; Cheng TP; Carroll SL
    J Neurooncol; 2004 Feb; 66(3):273-84. PubMed ID: 15015657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
    Frogne T; Benjaminsen RV; Sonne-Hansen K; Sorensen BS; Nexo E; Laenkholm AV; Rasmussen LM; Riese DJ; de Cremoux P; Stenvang J; Lykkesfeldt AE
    Breast Cancer Res Treat; 2009 Mar; 114(2):263-75. PubMed ID: 18409071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.
    Ratchford AM; Baker OJ; Camden JM; Rikka S; Petris MJ; Seye CI; Erb L; Weisman GA
    J Biol Chem; 2010 Mar; 285(10):7545-55. PubMed ID: 20064929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.
    Egeblad M; Jäättelä M
    Int J Cancer; 2000 Jun; 86(5):617-25. PubMed ID: 10797281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuregulin-1 enhances survival of human astrocytic glioma cells.
    Ritch PS; Carroll SL; Sontheimer H
    Glia; 2005 Aug; 51(3):217-28. PubMed ID: 15812817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation.
    Buac K; Xu M; Cronin J; Weeraratna AT; Hewitt SM; Pavan WJ
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):773-84. PubMed ID: 19659570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells.
    Kornblum HI; Yanni DS; Easterday MC; Seroogy KB
    Dev Neurosci; 2000; 22(1-2):16-24. PubMed ID: 10657694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.
    Stoll SW; Kansra S; Peshick S; Fry DW; Leopold WR; Wiesen JF; Sibilia M; Zhang T; Werb Z; Derynck R; Wagner EF; Elder JT
    Neoplasia; 2001; 3(4):339-50. PubMed ID: 11571634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
    Smirnova T; Zhou ZN; Flinn RJ; Wyckoff J; Boimel PJ; Pozzuto M; Coniglio SJ; Backer JM; Bresnick AR; Condeelis JS; Hynes NE; Segall JE
    Oncogene; 2012 Feb; 31(6):706-15. PubMed ID: 21725367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the C-terminal linear region of EGF-like growth factors in ErbB specificity.
    van der Woning SP; Venselaar H; van Rotterdam W; Jacobs-Oomen S; van Leeuwen JE; van Zoelen EJ
    Growth Factors; 2009 Jun; 27(3):163-72. PubMed ID: 19384683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
    Alvarado D; Ligon GF; Lillquist JS; Seibel SB; Wallweber G; Neumeister VM; Rimm DL; McMahon G; LaVallee TM
    PLoS One; 2017; 12(7):e0181356. PubMed ID: 28723928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
    Stindt S; Cebula P; Albrecht U; Keitel V; Schulte am Esch J; Knoefel WT; Bartenschlager R; Häussinger D; Bode JG
    PLoS One; 2016; 11(2):e0148711. PubMed ID: 26886748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.